Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Rimonabant in overweight women with prior gestational diabetes
2007-000907-13Phase 4Completed
- Sponsor
- Medical University of Vienna, Department of Endocrinology and Metabolism
- Start
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of rimonabant in prediabetes, Overweight, gestational diabetes mellitus (GDM) and 1 more (2 arms), sponsored by Medical University of Vienna, Department of Endocrinology and Metabolism. Primary endpoint: Plasma lipids. Started Oct 2007; status: completed.
02
Drugs
rimonabant
03
Conditions
prediabetesOverweightgestational diabetes mellitus (GDM)dyslipidemia
Beyond the preview
Go deeper on 2007-000907-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000907-13.